Here's what we'll cover
Here's what we'll cover
Compounded semaglutide and tirzepatide became popular because they cost far less than brand name Ozempic, Wegovy, Mounjaro, and Zepbound. During the shortage years, many patients paid a few hundred dollars a month instead of more than $1,000.
The landscape in late 2026 looks very different. The shortages are over, the FDA is closing the legal pathways for mass compounding, and brand self pay prices have dropped sharply. Here is what compounded GLP-1s are, what the documented risks are, and how to decide.
What Compounded Means
Compounding is when a licensed pharmacy mixes or alters ingredients to make a customized drug, for example for a patient allergic to an ingredient in the approved product. It has a legitimate place in medicine.
The key point: compounded drugs are not FDA approved. The FDA does not review them for safety, effectiveness, or quality before they reach patients.
Why the FDA Has Raised Concerns
Dosing Errors
Compounded semaglutide often comes in multidose vials with concentrations that differ from the approved pens. The FDA has alerted providers and patients to reports of people giving themselves five to 20 times the intended dose, with some needing hospital care for nausea, vomiting, dehydration, and low blood sugar.
Salt Forms and Unknown Products
The FDA has warned that some products contain semaglutide sodium or semaglutide acetate, salt forms that differ from the active ingredient in approved medicines and have not been shown to be safe and effective. It has also flagged products labeled for research use only and counterfeit products.
Sterility and Quality
Injectables must be sterile. Traditional 503A pharmacies are overseen mainly by state boards, while 503B outsourcing facilities register with the FDA and follow federal manufacturing standards. Online sellers without clear pharmacy credentials offer the least protection.
| Pharmacy type | Who it serves | Oversight | Quality standards |
|---|---|---|---|
| 503A (traditional) | Individual patients with a prescription | Mainly state boards of pharmacy | Vary by state |
| 503B (outsourcing facility) | Larger volumes for clinics and hospitals | FDA registered and inspected | Federal current good manufacturing practice |
You can check whether a facility is on the FDA's registered outsourcing facility list.
What Happened When the Shortages Ended
Pharmacies were legally allowed to copy these drugs while they were in shortage. The FDA removed tirzepatide from its shortage list in December 2024 and semaglutide in February 2025, then gave compounders wind down periods that ended in spring 2025, as described in its compounding policy update.
Some compounders kept going by claiming personalized formulations. The FDA has pushed back:
- On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, finding no clinical need for bulk compounding when approved versions exist. The comment period closed June 29, 2026.
- In June 2026, the FDA sent warning letters to 25 telehealth companies over misleading claims about compounded GLP-1 products, as reported by Bloomberg Law.
- If you still receive a compounded product, ask your provider which pharmacy makes it and whether it can legally continue.
The Cost Gap Has Shrunk
Price was the main reason to choose compounding. That advantage is much smaller now.
| Option | Typical monthly cost (Oct 2026) | FDA approved? |
|---|---|---|
| Compounded semaglutide or tirzepatide | About $150 to $500 | No |
| Wegovy pill (manufacturer self pay) | About $149 to $299 by dose | Yes |
| Wegovy pen (manufacturer self pay) | About $199 for initial doses, $349 at maintenance | Yes |
| Zepbound (LillyDirect self pay) | About $299 to $449 by dose | Yes |
| Medicare GLP-1 Bridge | $50 copay for eligible enrollees | Yes |
Prices change often, so confirm current amounts before you buy, and check GLP-1 coupons and savings programs. Eligible Medicare Part D enrollees can get Wegovy, Zepbound, or Foundayo for $50 a month through the Medicare GLP-1 Bridge through December 31, 2027.
Red Flags to Watch For
- No prescription or medical evaluation required
- Products labeled for research use only or not for human consumption
- Semaglutide sodium or acetate on the label
- No named pharmacy, license number, or batch information
- Vials that arrive warm, cloudy, or without clear dosing instructions in milligrams and units
- Prices far below even compounded market rates
Questions to Ask Before You Use a Compounded GLP-1
- Which pharmacy makes this product, and is it 503A or 503B?
- Is the active ingredient semaglutide or tirzepatide base, not a salt form?
- Can I see a certificate of analysis for this batch?
- How many units equal my prescribed milligram dose?
- Would a brand self pay program cost about the same?
No waiting list. No insurance needed.
Frequently Asked Questions
Are compounded GLP-1 drugs FDA approved?
No. Compounded semaglutide and tirzepatide are not FDA approved. The FDA does not review them for safety, effectiveness, or quality before they are dispensed.
Is compounded semaglutide still legal in 2026?
The shortage based allowance ended in 2025. Limited compounding for a documented individual clinical need may still occur, but the FDA proposed in April 2026 to exclude semaglutide and tirzepatide from 503B bulk compounding and has issued warning letters to telehealth companies.
What are the main risks of compounded GLP-1s?
The FDA has documented dosing errors from concentration differences, products containing unapproved salt forms such as semaglutide sodium or acetate, research only products, and counterfeit products.
What is the difference between 503A and 503B pharmacies?
503A pharmacies compound for individual prescriptions and are mainly overseen by state boards. 503B outsourcing facilities register with the FDA, are inspected, and follow federal manufacturing standards.
How much does brand name Wegovy or Zepbound cost without insurance now?
As of October 2026, manufacturer self pay prices start around $149 per month for the lowest Wegovy pill dose, about $199 for initial Wegovy pen doses, and about $299 for starting doses of Zepbound.
How can I avoid a dosing error with a compounded vial?
Confirm your dose in milligrams, the vial concentration in mg per mL, and the exact number of units to draw with your provider or pharmacist before every new vial.
The Bottom Line
Compounded GLP-1s helped many people during the shortage years, but they are not FDA approved, and the FDA has documented dosing errors, unapproved salt forms, and fake products. The shortages ended in 2024 and 2025, and in 2026 the FDA moved to end bulk compounding of semaglutide and tirzepatide entirely.
The good news is that approved options now cost far less than they did. Before choosing a compounded product, compare manufacturer self pay prices, the Medicare GLP-1 Bridge if you qualify, and current GLP-1 coupons and savings programs. To find a prescriber who uses FDA approved medications and offers real clinical follow up, compare vetted telehealth providers. Always consult your physician before starting or switching any GLP-1 medication.